Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for APREMILAST
- A Study to Investigate Efficacy and Safety of Apremilast 30 mg Twice Daily (BID) in Chinese Participants With Moderate to Severe Plaque-type Psoriasis (PsO)
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period
- A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
- A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 52 Weeks of Treatment
- Topical Pentoxifylline; Metformin Versus Betamethasone in the Treatment of Alopecia Areata.
- Bioequivalence Study of Two Products of Apremilast 30 mg Tablets in Healthy, Adult, Human Subjects
- Apremilast for Erythema Multiforme
- A Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
- Adherence to Otezla
- A Study to Assess the Efficacy and Safety of Apremilast in Japanese Pediatric Participants With Moderate to Severe Plaque Psoriasis
- Phase 3, Randomized Study of Apremilast in Japanese Participants With Palmoplantar Pustulosis (PPP)
- Study of Subcutaneous Risankizumab Injection Compared to Oral Apremilast Tablets to Assess Change in Disease Activity And Adverse Events in Adult Participants With Moderate Plaque Psoriasis Who Are Candidates for Systemic Therapy
- A Study to Determine the Efficacy and Safety of Deucravacitinib Compared With Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Are Naïve to Biologic Disease Modifying Anti-rheumatic Drugs or Had Previously Received TNFα Inhibitor
- A Study to Evaluate the Efficacy and Safety of Apremilast in Patients of Chronic and Recurrent Erythema Nodosum Leprosum
- A Study in Healthy People to Compare 3 Different Formulations of Apremilast Tablets Taken With or Without Food
- Apremilast Pediatric Study in Children With Active Juvenile Psoriatic Arthritis
- Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis
- Study of Multiple Candidate Agents for the Treatment of COVID-19 in Hospitalized Patients
- Apremilast in Patients With Moderate to Severe Palmoplantar Pustulosis (PPP) (APLANTUS)
- Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
- Danish Population-based Assessment of Psoriasis and Psoriatic Arthritis (DANPAPP)
- I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients
- Apremilast 30 mg BID Combined With Dupilumab
- Randomized Double Blind Controlled Trial Comparing the Safety and Efficacy of Apremilast Versus Placebo in Severe Forms of Recurrent Aphthous Stomatitis
- A Long-term Extension Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
- Preliminary Efficacy and Safety of Apremilast in the Treatment of Acne Conglobata
- Validation of the PsASon ULtrasound Scores in Patients With Psoriatic Arthritis Undergoing TReatment With Apremilast
- A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Japanese Subjects With Palmoplantar Pustulosis
- A Study of the Efficacy and Safety of Apremilast, in Subjects With Plaque Psoriasis That is Not Adequately Controlled by Topical Therapy
- Apremilast - Oral Lichen Planus Trial
- A Study to Evaluate the Impact of Apremilast (CC-10004) on MRI Outcomes in Subjects With Psoriatic Arthritis
- An Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate to Severe Genital Psoriasis
- A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Subjects With Manifestations of Plaque Psoriasis and Impaired Quality of Life
- Efficacy, Safety, and Tolerability Study of Apremilast to Treat Early Oligoarticular Psoriatic Arthritis.
- Apremilast and Moderate to Severe Chronic Hand Dermatitis
- Apremilast as a Direct Treatment for Mild-to-moderate Plaque Psoriasis Versus Placebo: an Analysis of Clinical Safety and Efficacy
- Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis
- Apremilast for RAS
- The AP-GELP Study: A Clinical Trial on the Effects of Apremilast in Female Genital Erosive Lichen Planus
- Effectiveness and Safety of BMS-986165 Compared to Placebo and Active Comparator in Participants With Psoriasis
- An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
- Apremilast as Anti-pruritic Treatment in Patients With Prurigo Nodularis
- Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
- Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis
- Apremilast in the Treatment of Central Centrifugal Cicatricial Alopecia (CCCA)
- Monocyte Biomarkers in Moderate to Severe Plaque Psoriasis Subjects Treated With Apremilast
- Efficacy and Safety of Enstilar Foam in Combination With Apremilast (Otezla) in Patients With Moderate Plaque Psoriasis
- Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia
- A Study Examining the Medication Apremilast as Treatment for Chronic Itch
- Assessment of the Clinical and Ultrasound Response to Apremilast by Clinical Evaluation and by a Joint-periarticular-nail Ultrasound Index in Patients With Active Psoriatic Arthritis
- Medication Development in Alcoholism: Apremilast Versus Placebo
- CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis
- An Investigator-initiated Study of Apremilast to Demonstrate Efficacy Nummular Eczema
- Analysis of the Pathogenesis of Itch in Response to Apremilast Therapy in Psoriasis Patients
- A Study of the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Moderate to Severe Plaque Psoriasis of the Scalp
- Combined Therapy With Narrow-Band Ultraviolet B Phototherapy and Apremilast for the Treatment of Vitiligo
- Vascular Inflammation in Psoriasis - Apremilast
- Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis
- Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO
- An Investigator Initiated Open Label Study Evaluating the Efficacy and Tolerability of Oral Apremilast for the Treatment of Nail Psoriasis
- Use of Apremilast in Patients Who Are Dissatisfied With Stable Maintenance Topical Therapy
- A Study of LY2775240 in Healthy Participants
- APremilast After FumaRic Acid Ester Treatment
- Study to Evaluate the Pharmacokinetics of Single and Multiple Doses of Apremilast in Healthy Adult Male Korean Subjects
- A Study to Evaluate the Pharmacokinetic Exposure of 2 Formulations of Apremilast in Healthy Adults
- Apremilast Pregnancy Exposure Registry
- Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast
- Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
- Single Center Study of Apremilast for the Treatment of Hidradenitis Suppurativa
- Pilot Study of the Safety and Efficacy of Apremilast in Subjects With Moderate to Severe Alopecia Areata
- Study to Evaluate Bioavailability of Apremilast Oral Suspension Relative to Tablet and to Assess Effect of Food on the Pharmacokinetics (PK) of the Oral Suspension
- A Study of Safety, Tolerability and Pharmacokinetics of Apremilast (CC-10004) in Pediatric Subjects With Moderate to Severe Plaque Psoriasis
- Treatment With Apremilast in Patients With Psoriatic Arthritis
- A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
- A Phase 4 Study of Efficacy and Safety of Apremilast in Subjects With Moderate Plaque Psoriasis.
- Apremilast 30mg Bid With Narrowband UVB in the Treatment of Plaque Psoriasis
- Apremilast in Palmo-Plantar Psoriasis
- A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease
- Efficacy and Safety Study of Apremilast to Treat Active Ulcerative Colitis
- Study to Evaluate Pharmacokinetics of Prototype Modified-Release Formulations Of Apremilast in Healthy Men
- Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis
- Efficacy and Safety Study of Apremilast in Subjects With Moderate to Severe Atopic Dermatitis
- Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Patients With Moderate-To-Severe Plaque-Type Psoriasis
- Safety and Efficacy Study of Apremilast to Treat Psoriatic Arthritis
- Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis
- Effects of Age and Sex on the Pharmacokinetics of Apremilast in Healthy Adults
- Effect of Food on the Pharmacokinetics of Apremilast (CC-10004) in Healthy Adults
- Study of Apremilast to Treat Subjects With Active Ankylosing Spondylitis
- A Drug-Drug Interaction Study to Evaluate the Effect of Rifampin on the Pharmacokinetics of Apremilast
- Apremilast for Atopic Dermatitis - A Pilot Study in Adults
- Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis (PsA)
- Study of Apremilast to Evaluate the Safety and Effectiveness for Patients With Rheumatoid Arthritis
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis.
- PALACE 3: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
- PALACE 2: Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
- Concomitant Use of Apremilast for the Treatment of Active RA Despite TNF-Inhibition and Methotrexate- CATARA
- Efficacy Study of Apremilast (CC-10004) in Subjects With Erosive Hand Osteoarthritis
- Apremilast for Chronic Plaque Psoriasis (CPP) Patients Who Have Failed One Course of Biologic Therapy
- Study to Evaluate Safety and Effectiveness of Oral Apremilast (CC-10004) in Patients With Moderate to Severe Plaque Psoriasis
- Efficacy and Safety Study of Apremilast to Treat Active Psoriatic Arthritis
- A Study to Evaluate the Safety and Efficacy of Apremilast in the Treatment of Skin Disease in Patients With Dermatomyositis
- Apremilast in the Treatment of Moderate to Severe Acne
- Open Label Pilot Study of Apremilast in Treatment of Rosacea
- Pilot Study of Apremilast (CC-10004) in the Treatment of Moderate to Severe Lichen Planus
- Apremilast Therapy for Acute Gouty Arthritis
- Spondylitis Trial of Apremilast for Better Rheumatic Therapy
- Study of Apremilast in Atopic or Contact Dermatitis
- Apremilast in the Treatment of Uveitis
- Safety and Efficacy of CC-10004 for Prurigo Nodularis
- A Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in the Treatment of Behçet Disease
- Efficacy and Safety Study of Apremilast (CC-10004) in Subjects With Moderate-to-Severe Plaque-Type Psoriasis (Core Study)
- Safety Study of Clinical and Immune Effects of Phosphodiesterase 4 (PDE-4) Inhibitor in Cutaneous Lupus Patients
- Double-Blind, Randomized, Placebo-controlled Comparison of CC-10004 in Subjects With Moderate to Severe Plaque Type Psoriasis
- Open-Label,Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC1004 in Subjects With Severe Plaque Type Psoriasis
- Apremilast Safety and PK Study in Recalcitrant Plaque Psoriasis
- Phase II Study of Apremilast (CC-10004) in Adults With in Psoriatic Arthritis
Clinical trials list
click for details